From July 28th to 29th, the 10th China Finance Summit with the theme of "growth" was held in Shanghai. As the Model Enterprise, selected by the conference, promoting economic growth and social progress in the new era, CHIC Health stood out from many enterprises with strong development potential and won the " 2021 investment value award ".
The China Finance Summit, established in 2012, is a brand event collectively organized by domestic authoritative financial and mass media. The summit gathered and shared business wisdom in various forms, including speeches, high-level dialogues, in-depth sharing, project roadshows, tribute ceremony, brand exhibitions and other forms, looked forward to the general trend of China's economic development, and explored the drivers for China's economic transformation and development. This summit once again brought together far-sighted business leaders, economic leaders, entrepreneurs and representatives of new youths at home and abroad to admonish the path of China's economic upgrading, and jointly exploring the path of high-quality growth in the context of the new era.
CHIC Health was selected, according to the six indicators of "innovation, responsibility, influence, driving force, growth, and forward-looking", after a comprehensive evaluation of the review committee of the summit. Since its establishment, CHIC Health has been focusing on the field of chronic respiratory diseases, focusing on the development of a disease management systems and digital products of diagnosis and treatment. The company, founded only one year ago, has built a clear business model in the field of chronic respiratory diseases.
Last year, CHIC Health has completed tens of millions of angel rounds of financing invested by Matrix Partners China in order to accelerate the establishment of a full-process management platform for respiratory diseases. At present, the company's standardized management system for chronic obstructive pulmonary disease has been implemented in Zhumadian City, Henan Province. More than 5,000 physicians have registered and used it, realizing the standardized management of 850,000 people with chronic obstructive pulmonary disease. CHIC Health’s pre-diagnosis assessment system for chronic respiratory diseases has covered more than 1,500 hospitals across the country and completed risk assessments of over 4.2 million people. On the other hand, it is developing digital diagnosis and treatment products with clinical value based on accurate data accumulation. In the future, the company will continue to develop its investment value potential, grow into a leading company in the industry, and strive to build a leading platform in the field of respiratory disease management.
This award is also an affirmation of CHIC Health from all walks of life. The company will continue to uphold the concept of " Intelligence Inspired Better Health ", and cooperate with more partners to continuously stimulate new life of the industry and promote the development of the healthcare industry.